THE EFFICACY OF AMLODIPINE AND DILTIAZEM IN CYCLOSPORINE DOSE ADJUSTMENT WITH RESPECT TO TROUGH AND 2-HOUR CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AZMANDIAN J.; SOHREVARDI S.M.; FAZELI F.; ETMINAN ABAS; SARVERAM ALI; AFZAL FARNAZ

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Kerman University of Medical Sciences Year:2009 | Volume:16 | Issue:3 Page(s): 197-205

Download Full-Text

Persian Verion

View:

2,524

Download:

Cites:

Information Journal Paper

Title

THE EFFICACY OF AMLODIPINE AND DILTIAZEM IN CYCLOSPORINE DOSE ADJUSTMENT WITH RESPECT TO TROUGH AND 2-HOUR CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS

Author(s)

Keywords

CYCLOSPORINEQ3

AMLODIPINEQ2

DILTIAZEMQ3

RENAL TRANSPLANTATIONQ3

Abstract

Background & Aims: Hypertension, hyperuricaemia and nephrotoxicity are some common side-effects of CYCLOSPORINE A (CsA) treatment in renal transplant recipients. Previous studies suggest that Calcium Channel Blockers (CCB) can increase serum level of CsA and may improve graft function in patients receiving CsA. The aim of this study was to evaluate the effects of DILTIAZEM and AMLODIPINE on CYCLOSPORINE dose adjustment with respect to trough and 2-hour concentrations in renal transplant recipients treated with CsA.Methods: This observer-blind randomized clinical trial was performed on 120 renal transplant recipients treated with CsA. Patients received either AMLODIPINE (5-10mg/day) or DILTIAZEM (90-180mg/day) for 3 months and were compared with control group receiving no CCB. Data were analyzed using ANOVA, Post Hoc and Correlation tests.Results: DILTIAZEM significantly decreased CsA dosage (20%) from 162.03±40.6 mg/dl to 128.5± 25.5 mg/dl (P=0.000) and AMLODIPINE, too, decreased it to 140.5±22.3 mg/dl (13%) which was significant (P=0.008). Trough concentration in patients who had received AMLODIPINE were significantly higher than control group (P=0.019). DILTIAZEM significantly decreased Cholesterol Level (P=0.027) but other parameters were not significantly different between AMLODIPINE / DILTIAZEM and control groups. Discussion: DILTIAZEM and AMLODIPINE were well tolerated in co-administration with CsA with no adverse effect on graft function and did not affect blood pressure or heart rate. Our findings support that these two CCBs can be used in clinical settings to reduce the administered dose of CYCLOSPORINE.

Cites

No record.

References

No record.

Cite

APA: Copy

AZMANDIAN, J., SOHREVARDI, S.M., FAZELI, F., ETMINAN, ABAS, SARVERAM, ALI, & AFZAL, FARNAZ. (2009). THE EFFICACY OF AMLODIPINE AND DILTIAZEM IN CYCLOSPORINE DOSE ADJUSTMENT WITH RESPECT TO TROUGH AND 2-HOUR CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, 16(3), 197-205. SID. https://sid.ir/paper/574/en

Vancouver: Copy

AZMANDIAN J., SOHREVARDI S.M., FAZELI F., ETMINAN ABAS, SARVERAM ALI, AFZAL FARNAZ. THE EFFICACY OF AMLODIPINE AND DILTIAZEM IN CYCLOSPORINE DOSE ADJUSTMENT WITH RESPECT TO TROUGH AND 2-HOUR CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2009;16(3):197-205. Available from: https://sid.ir/paper/574/en

IEEE: Copy

J. AZMANDIAN, S.M. SOHREVARDI, F. FAZELI, ABAS ETMINAN, ALI SARVERAM, and FARNAZ AFZAL, “THE EFFICACY OF AMLODIPINE AND DILTIAZEM IN CYCLOSPORINE DOSE ADJUSTMENT WITH RESPECT TO TROUGH AND 2-HOUR CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS,” JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, vol. 16, no. 3, pp. 197–205, 2009, [Online]. Available: https://sid.ir/paper/574/en

Related Journal Papers